Signal2026-07-10
ClinicalTrials.gov

[PHASE3] Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Part of

Molecular Profiling In Endocrine Neoplasms

Open primary sourceSee the whole picture